Page 2 - Biotech Bioengineering News Today

Dalan Animal Health’s vaccine for American foulbrood, an aggressive bacterial disease, is the first for any insect in the United States.

One company believes the possibilities go beyond vegan “meat,” from faux leather to luxury skin-care products. But is there enough demand outside of food alternatives?

Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.

His research into recombinant DNA provided a foundation for the biotech revolution, leading to a long list of lifesaving treatments.

Researchers in Atlanta have helped the federal government evaluate dozens of Covid tests and pioneer a new model for developing novel diagnostics.

Nasal vaccines under development around the world may make better boosters by stopping the coronavirus in the airways.

A new study finds the first known instance of a human-engineered hybrid, bred from a donkey and a Syrian wild ass 4,500 years ago.

The Commerce and Treasury Departments put new restrictions on an array of companies and institutions that they said were misusing biotechnology.

The Commerce and Treasury Departments put new restrictions on an array of companies and institutions that they said were misusing biotechnology.

Researchers can now design and mass-produce genetic material — a technique that helped build the mRNA vaccines. What could it give us next?